A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.

Pfizer412 enrolled

Overview

This is a study to investigate the safety and efficacy of voriconazole for the treatment of candidemia in critically ill non-neutropenic patients

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

412

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with candidemia Exclusion Criteria: * Neutropenia

Sustained clinical response for 12 weeks from end of treatment

Time to negative blood cultures

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.